A new study from Brazil suggests that the "sunshine vitamin" could play a powerful role in improving breast cancer treatment. Researchers at São Paulo State University found that women who received daily vitamin D supplements alongside chemotherapy were far more likely to see their tumors disappear compared to those given a placebo.
The trial involved 80 women over the age 45, all undergoing neoadjuvant chemotherapy- treatment given before surgery to shrink tumors. Half of the participants received 2,000 IU of vitamin D each day, while the other half received a placebo. After six months, 43 percent of the women taking vitamin D had no detectable cancer, compared to just 24 percent in the placebo group.
The researchers described this as a striking improvement, noting that even a relatively low dose of vitamin D appeared to enhance the effectiveness of chemotherapy.
Vitamin D, often called the sunshine vitamin because the body produces it naturally when exposed to sunlight, is known to support immune function and bone health. In this study, most participants began with low vitamin D levels, and supplementation helped raise those levels during treatment. The researchers believe that boosting vitamin D may strengthen the body's ability to fight cancer and improve how patients respond to therapy.
While the findings are promising, the team emphasized that larger studies are needed to confirm results. They also suggested that future research could explore different dosing regimens, longer follow-up periods, and how vitamin D interacts with factors such as age, genetics, and lifestyle. Importantly, they cautioned that vitamin D is not a replacement for cancer treatment but rather a potential supportive therapy.
Courtesy: Science Direct
For comments and feedback: editorial@rttnews.com